News

Revolutionary NEUROMARK Treatment Offers Long-Lasting Relief

Revolutionary NEUROMARK Treatment Offers Long-Lasting Relief

Lasting Impact of the NEUROMARK Treatment on Chronic Rhinitis

PARAGON Study Demonstrates Efficacy and Safety in Patients

Neurent Medical is making strides in the treatment of chronic rhinitis with its innovative NEUROMARK System. This non-surgical solution has been shown to provide significant, long-lasting relief for patients suffering from both allergic and nonallergic rhinitis. The latest findings from the PARAGON clinical study highlight the substantial clinical benefits of this treatment over a two-year period.

The study, published in a respected medical journal, demonstrates that the NEUROMARK treatment leads to meaningful improvements in symptoms for patients, significantly enhancing their overall quality of life. With groundbreaking results, Neurent Medical is at the forefront of addressing chronic sinonasal diseases.

Understanding the Results of the NEUROMARK Treatment

In the PARAGON study, the findings showcased some impressive statistics on the treatment's efficacy:

  • The reflective Total Nasal Symptom Score (rTNSS) improved by 55% from the baseline after two years, which is statistically significant.
  • An impressive 76% of participants reported a substantial reduction in their symptom scores, indicating effectiveness in managing their conditions.
  • Furthermore, 91% of participants achieved the minimum clinically important difference (MCID), highlighting the notable improvements experienced.
  • All key symptom subscores, including congestion, rhinorrhea, sneezing, itching, and related symptoms, showed significant and sustained improvement throughout the two-year period.
  • Significantly, both the Nasal Obstruction Symptom Evaluation (NOSE) score and its subscores remained advantageous after two years.
  • The treatment also positively impacted quality of life, with 79% of participants achieving an MCID in the mini-Rhinoconjunctivitis Quality of Life Questionnaire (mini-RQLQ).
  • Moreover, the Eustachian Tube Dysfunction Questionnaire (ETDQ-7) indicated substantial long-term improvements.
  • Both allergic and nonallergic patients showed equally successful outcomes, indicating broad applicability of the treatment.

Expert Perspectives on the Findings

Dr. David Yen, MD, a prominent figure in the study, emphasized the importance of these results. He stated, "These long-term results provide robust evidence that NEUROMARK offers durable relief for patients suffering from chronic rhinitis, addressing not only nasal symptoms but also postnasal drip, cough, and ear-related complaints. The consistency of improvements through two years underscores the potential for NEUROMARK to be a transformative therapy for this difficult-to-treat condition."

Brian Shields, CEO of Neurent Medical, expressed his excitement regarding the study's findings. He remarked, "We are delighted to share these results, reinforcing our commitment to provide minimally invasive solutions that enhance patients' lives and empower ENT physicians with efficient tools for managing chronic rhinitis."

About the NEUROMARK System

The NEUROMARK System is specifically designed for use in otorhinolaryngology. It functions through the creation of radiofrequency lesions targeted at the posterior nasal nerves, thus providing relief from chronic rhinitis symptoms. By applying controlled, low-power radiofrequency energy, the device effectively interrupts parasympathetic nerve signaling, reducing inflammation and alleviating discomfort for patients experiencing congestion and rhinorrhea.

About Neurent Medical

Neurent Medical is dedicated to innovating treatments for chronic sinonasal diseases. Their proprietary NEUROMARK technology utilizes a unique design and advanced algorithmic control, enabling precise targeting of multiple nerve branches in one treatment session. With its headquarters in Galway, Ireland, and operations expanding into the U.S. market, Neurent Medical is supported by leading venture capital firms seeking to revolutionize the ENT landscape.

Frequently Asked Questions

What is the NEUROMARK treatment?

The NEUROMARK treatment is a non-surgical procedure designed to improve symptoms of chronic rhinitis through controlled radiofrequency energy aimed at specific nasal nerves.

How long do the benefits of the NEUROMARK treatment last?

According to recent studies, the NEUROMARK treatment shows sustained efficacy and safety over a two-year period.

What symptoms does NEUROMARK address?

NEUROMARK targets various symptoms associated with chronic rhinitis, including congestion, sneezing, postnasal drip, and coughing.

Is the NEUROMARK treatment suitable for everyone?

The NEUROMARK treatment is aimed at patients with chronic rhinitis, including both allergic and nonallergic forms. Consultation with a healthcare provider is recommended to determine suitability.

Who is behind Neurent Medical?

Neurent Medical is a pioneering company focused on innovative solutions for chronic inflammatory sinonasal diseases, proud of its innovative approach and robust investment backing.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 332

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 199

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 509

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 47

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 19

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 287

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 78

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 241

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading

Top 5 Most Recently Viewed Articles

Liberty Tire Recycling Raises Substantial Funds for Childhood Hunger

Updated Category News Views 47

Liberty Tire Recycling's Philanthropic Efforts Liberty Tire Recycling has impressively raised $87,805 to support Blessings in a Backpack, an organization dedicated to combating childhood hunger. This significant amount was a result of several engaging events, including a charity golf tournament and multiple packing sessions, where employees actively participated....

Continue Reading
Future of Surface Disinfectant Products and Market Growth

Updated Category News Views 184

Growth of the Surface Disinfectant Products Market The surface disinfectant products market is on a promising trajectory, forecasted to reach USD 65.7 billion by 2035, with a compound annual growth rate (CAGR) of 4.8% starting in 2025. This growth reflects a broader trend towards increased consciousness around hygiene and health safety, particularly in light of recent...

Continue Reading
Cryptocurrency Market Update: Bitcoin and Ethereum Trends

Updated Category News Views 226

Cryptocurrency Market Overview As of Tuesday morning, the cryptocurrency market is experiencing a decline, with Bitcoin's price falling to $113,000 amidst ongoing negotiations regarding a government shutdown in the U.S. This pivotal moment has left investors analyzing market movements closely. Key Cryptocurrency Prices The current prices for major cryptocurrencies are as...

Continue Reading
Market Positioning Insights and Risks: What Investors Should Know

Updated Category News Views 68

S&P 500 Positioning Risks Highlighted by Citi Recent analysis by Citi strategists reveals concerning trends in the S&P 500's positioning, now at levels not seen in the past three years. This significant rise in positioning makes the index noticeable among other markets, where investor conviction remains unsteady. Understanding Market Pullbacks Historical data emphasizes a...

Continue Reading
Galmed Pharmaceuticals Unveils Innovative Digital Asset Strategy

Updated Category News Views 126

Galmed Pharmaceuticals' Strategic Move into Digital Assets Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), a clinical-stage biopharmaceutical company specializing in the treatment of various diseases, has embarked on an innovative journey that dives into digital asset management. This strategic decision aims to enhance capital efficiency and bolster shareholder value through...

Continue Reading